British journal of clinical pharmacology 2024 Sep 08
Does dosing frequency of anti-CD20 therapies blunt vaccine responses and increase COVID-19 susceptibility in patients with multiple sclerosis?
Related Questions
In light of immunogenicity data of three-dose COVID-19 vaccines (Shawe-Taylor et al., PMID 41425831).
New answer by at University of Kentucky (March 3, 2026)
While anti-CD20 drugs may not influence innate and CD8 T cell responses, the effect of prolonged suppression of the humoral responses following with a fixed dosing schedule ne...